BioLineRx Ltd. Capital Reserve
BioLineRx Ltd. (BLRX) had Capital Reserve of $15.92 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:CapitalReserve · last filed 2026-03-23
- 2025-12-31: Capital Reserve $15.92M.
- 2025-06-30: Capital Reserve $17.15M.
- 2024-12-31: Capital Reserve $17.55M.
- 2024-06-30: Capital Reserve $17.97M.
| Period end | Capital Reserve |
|---|---|
| 2025-12-31 | $15.92M 20-F · filed 2026-03-23 |
| 2025-06-30 | $17.15M 6-K · filed 2025-08-14 |
| 2024-12-31 | $17.55M 20-F · filed 2026-03-23 |
| 2024-06-30 | $17.97M 6-K · filed 2024-08-15 |
| 2023-12-31 | $17.00M 20-F · filed 2025-03-31 |
| 2023-06-30 | $15.62M 6-K · filed 2023-08-30 |
| 2022-12-31 | $14.77M 20-F · filed 2024-03-26 |
| 2022-06-30 | $13.60M 6-K · filed 2022-08-16 |
| 2021-12-31 | $13.16M 20-F · filed 2023-03-22 |
| 2021-06-30 | $12.97M 6-K · filed 2021-08-18 |
| 2020-12-31 | $12.32M 20-F · filed 2022-03-16 |
| 2020-06-30 | $12.64M 6-K · filed 2020-08-06 |
| 2019-12-31 | $12.13M 20-F · filed 2021-02-23 |
| 2019-06-30 | $11.84M 6-K · filed 2019-08-06 |
| 2018-12-31 | $11.96M 20-F · filed 2020-03-12 |
| 2018-06-30 | $11.34M 6-K · filed 2018-08-13 |
| 2017-12-31 | $10.34M 20-F · filed 2019-03-28 |
| 2016-12-31 | $10.57M 20-F · filed 2018-03-06 |